BILE DUCT STENT INSERTION side effect
What is BILE DUCT STENT INSERTION ?BILE DUCT STENT INSERTION : Forteo Side Effects Report #5377244-8
Consumer or non-health professional from UNITED STATES reported FORTEO problem on June 20, 2007. Female patient, 46 years of age, was diagnosed with osteoporosis and was treated with FORTEO. After drug was administered, patient experienced the following problems/side effects: bile duct stent insertion, cholelithiasis, endoscopic retrograde cholangiopancreatography, hepatic enzyme increased, myalgia, . FORTEO dosage: unknown. Patient was hospitalized. Patient recovered.
BILE DUCT STENT INSERTION : Forteo Side Effects Report #5377244-8
FORTEO problem was reported by a Consumer or non-health professional from UNITED STATES on June 20, 2007. Female patient, 46 years of age, was diagnosed with osteoporosis and was treated with FORTEO. After drug was administered, patient experienced the following problems/side effects: bile duct stent insertion, cholelithiasis, endoscopic retrograde cholangiopancreatography, hepatic enzyme increased, myalgia, . FORTEO dosage: unknown. Patient was hospitalized. Patient recovered.
BILE DUCT STENT INSERTION : Vitamin Side Effects Report #5531592-7
Physician from UNITED STATES reported VITAMIN CAP problem on Nov 28, 2007. Male patient, 70 years of age, was diagnosed with hypertension and was treated with VITAMIN CAP. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, bile duct stent insertion, biliary sphincterotomy, blood amylase increased, blood creatinine increased, cholecystectomy, cholelithiasis, lipase increased, nausea, . VITAMIN CAP dosage: unknown. During the same period patient was treated with TRAMADOL, ASPIRIN, MELOXICAM, TERAZOSIN, SIMVASTATIN, AMLODIPINE, LOTREL. Patient was hospitalized. Patient recovered.
BILE DUCT STENT INSERTION : Radioselectan Side Effects Report #5562820-X
RADIOSELECTAN problem was reported by a Physician from FRANCE on Dec 10, 2007. Male patient, 60 years of age, was diagnosed with cholangiogram, bile duct stent insertion, liver transplant and was treated with RADIOSELECTAN. After drug was administered, patient experienced the following problems/side effects: angioedema, bile duct stent insertion, cholangiogram, cholestasis, dyspnoea, pyrexia, tongue oedema, . RADIOSELECTAN dosage: unknown. During the same period patient was treated with TAGAMET, ISOFLURANE, PROPOFOL, CELOCURIN, PERFALGAN, TAVANIC, CERTICAN, SEROPRAM. Patient was hospitalized. Patient recovered.
BILE DUCT STENT INSERTION : Rifampicin Side Effects Report #5517758-0
Physician from UNITED STATES reported RIFAMPICIN problem on Oct 31, 2007. Female patient, 26 years of age, was diagnosed with tuberculosis and was treated with RIFAMPICIN. After drug was administered, patient experienced the following problems/side effects: bile duct stenosis, bile duct stent insertion, biliary sphincterotomy, dyspepsia, hepatitis, pancreatitis, . RIFAMPICIN dosage: 600 MG/DAY, ORAL. During the same period patient was treated with ISONIAZID, PYRAZINAMIDE, ETHAMBUTOL HYDROCHLORIDE, PYRIDOXINE. Patient was hospitalized. Patient recovered.
BILE DUCT STENT INSERTION : Vitamin Side Effects Report #5477919-6
VITAMIN CAP problem was reported by a Physician from UNITED STATES on Oct 01, 2007. Male patient, 70 years of age, was diagnosed with hypertension and was treated with VITAMIN CAP. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, bile duct stent insertion, biliary sphincterotomy, blood amylase increased, blood creatinine increased, cholecystectomy, cholelithiasis, lipase increased, nausea, . VITAMIN CAP dosage: unknown. During the same period patient was treated with TRAMADOL, ASPIRIN, MELOXICAM, TERAZOSIN, SIMVASTATIN, AMLODIPINE, LOTREL. Patient was hospitalized. Patient recovered.
BILE DUCT STENT INSERTION : Vitamin Side Effects Report #5450172-5
Physician from UNITED STATES reported VITAMIN CAP problem on Sept 06, 2007. Male patient, 70 years of age, was diagnosed with hypertension and was treated with VITAMIN CAP. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, bile duct stent insertion, biliary sphincterotomy, cholecystectomy, cholelithiasis, nausea, pancreatitis, renal failure acute, vomiting, . VITAMIN CAP dosage: unknown. During the same period patient was treated with TRAMADOL, ASPIRIN, MELOXICAM, TERAZOSIN, SIMVASTATIN, AMLODIPINE, LOTREL. Patient was hospitalized. Patient recovered.